about
The effect of laser activation of 5,10,15,20-tetra-sulphophenyl-porphyrin loaded in K562 cells and human normal mononuclear cells.Mechanistic understanding of nanoparticles' interactions with extracellular matrix: the cell and immune systemCombined microwave and electron beam exposure facilities for medical studies and applications.Cell investigations simultaneously with exposure to 2.45 GHz microwaves.Protein microarray for complex apoptosis monitoring of dysplastic oral keratinocytes in experimental photodynamic therapyTherapy targets in glioblastoma and cancer stem cells: lessons from haematopoietic neoplasms.Increased number of fractionated irradiation sessions does not improve the cellular response to methyl aminolevulinate-mediated photodynamic therapy.Whole body microwave irradiation for improved dacarbazine therapeutical action in cutaneous melanoma mouse model.25-OH Vitamin D and Interleukin-8: Emerging Biomarkers in Cutaneous Melanoma Development and ProgressionChemically induced skin carcinogenesis: Updates in experimental models (Review).Variations in the expression of TIMP1, TIMP2 and TIMP3 in cutaneous melanoma with regression and their possible function as prognostic predictors.Reflectance confocal microscopy and dermoscopy for in vivo, non-invasive skin imaging of superficial basal cell carcinoma.Immune based therapy for melanomaHPV strain distribution in patients with genital warts in a female population sample.Immunomics in Skin Cancer - Improvement in Diagnosis, Prognosis and Therapy Monitoring.Signal transduction molecule patterns indicating potential glioblastoma therapy approaches.Omics Landscape in Disease Biomarkers Discovery.Protein bio-corona: critical issue in immune nanotoxicology.Toxicological and efficacy assessment of post-transition metal (Indium) phthalocyanine for photodynamic therapy in neuroblastomaFullerene-porphyrin nanostructures in photodynamic therapy.Immune-related biomarkers for diagnosis/prognosis and therapy monitoring of cutaneous melanoma.Tissular and soluble miRNAs for diagnostic and therapy improvement in digestive tract cancers.The immune system--a hidden treasure for biomarker discovery in cutaneous melanoma.Biomarkers in the diagnosis and early detection of pancreatic cancer.Proteomics focusing on immune markers in psoriatic arthritis.Chemokines in the melanoma metastasis biomarkers portrait.Proteomic Approaches for Biomarker Panels in Cancer.Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review).Monitoring Diabetic Nephropathy by Circulating Gangliosides.The C-terminal decapeptide of prothymosin α is responsible for its stimulatory effect on the functions of human neutrophils in vitro.Microwave synthesis, basic spectral and biological evaluation of some copper (II) mesoporphyrinic complexes.Platelet-activating factor acetylhydrolase activity in patients with chronic stable angina (preliminary results).Patients with primary antiphospholipid syndrome and coronary microvascular dysfunction--a distinct clinical subset.Action of some proteic and carbohydrate components of Symphytum officinale upon normal and neoplastic cells.Fluorescent porphyrin with an increased uptake in peripheral blood cell subpopulations from colon cancer patients.Immune parameters in the prognosis and therapy monitoring of cutaneous melanoma patients: experience, role, and limitationsSelective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses.Unstable angina is accompanied by immune cells dysfunction.Preliminary study on the immunologic background of good clinical outcome in rheumatoid arthritis patients after one month therapy with leflunomide.The in vitro action of a succussed substance on the proliferative response of human lymphocytes stimulated with phytohemagglutinin.
P50
Q33269921-970165DF-9372-4799-AB7B-AEC00E256BD8Q33831191-1772D925-7FE3-4DCD-AF97-DAD94486D540Q33839775-6E1B2386-944E-4C0A-88A4-FFF96BE9E48AQ33839781-9A3DD36B-679B-4081-9F74-A46FB3AFE6ABQ34017896-232352E4-6F9A-41B5-B453-CFC67D72E563Q34154786-EFEB29FB-DE5C-4B07-B741-9BBCC96CBAB4Q35055693-C6845F46-2A2D-4FA0-A352-632F4B7E6335Q35078662-41CF43F6-E795-44BA-8C83-3C703A6B2CB2Q36173268-F8828244-9EC5-4DE2-B871-52E7376B965CQ36738630-EE4ACB62-EE4B-4223-B746-57CD0E12BF4DQ36825423-2DC84796-1243-40B9-9DE9-F67439729831Q36825620-C21F64CF-5252-4100-931A-70DF2D0F8715Q36876757-E8C3EE54-578B-41C7-9913-DF1CE2059109Q37204759-3FA804E3-B38F-4B1E-A219-3BFC6F7E2BCBQ37290632-46169A43-4703-4E1E-BB67-482C0C840C01Q37360227-BE78F54A-01D2-4B1A-B4E7-288511F320C7Q37397045-E2D4296B-30F8-4B81-8FA0-9FFFFB3420AFQ37651354-C695166F-01ED-4877-A2CD-A6A53726B03FQ37688430-49CE3F83-7374-466E-9644-CACE3BA0986CQ37690697-FCA58BBB-D1FE-4910-8696-4EEE157BB386Q37801939-CC7EB1EE-EDFC-4C18-B205-120C422EFA3CQ37822465-192206D8-CFF4-406E-9262-D481D6CC7999Q38040807-483CB238-2561-4EE4-A48D-C2B5660F3974Q38089821-9008F0A0-46FF-4E78-9A97-C969DD1168C1Q38230695-CD0015F1-4367-41C4-BC55-E899FC973156Q38403945-99416B83-3E16-4FF2-AEDA-4B806D3BA414Q38632577-E98B9047-5350-4274-AF40-F54835739B49Q38676352-7AD85F6B-F51E-4244-9BF4-D0ED3E42B6C3Q38993651-CA2C7543-9228-4B6D-9AC3-F465E213F7E9Q39234609-52BB7565-50F3-45F7-8205-4E8E7C50B7AAQ39676116-30E6699E-61AB-4AD1-9A71-6953BDC2DD38Q39699608-1D6E3047-064E-4C1B-841A-9B9CA50AE809Q39740076-2BAF17AB-1DCB-404E-AE54-85B41435DD24Q41564135-2F3C574F-0538-4DB0-9540-D8D88C0E7DEAQ41714798-D14C34BA-8D2F-41A8-85D8-04A053DF2416Q41868127-213CA463-6D2A-4824-960C-6512BD677C03Q41881939-54B3FD25-C583-4541-938F-7A3EAFE4285FQ42507140-6524A7C4-F0F2-4A93-B791-A90D560BD80BQ43591934-ECFCC16D-2C2C-4988-8E67-196A05BD0572Q43610772-28057BAC-A696-4FBF-8D3E-C9D324B182BF
P50
description
hulumtuese
@sq
researcher
@en
հետազոտող
@hy
name
Monica Neagu
@ast
Monica Neagu
@en
Monica Neagu
@es
Monica Neagu
@nl
Monica Neagu
@sl
type
label
Monica Neagu
@ast
Monica Neagu
@en
Monica Neagu
@es
Monica Neagu
@nl
Monica Neagu
@sl
prefLabel
Monica Neagu
@ast
Monica Neagu
@en
Monica Neagu
@es
Monica Neagu
@nl
Monica Neagu
@sl
P1053
C-3240-2011
P106
P1153
7006911336
P21
P2798
P31
P3829
P496
0000-0001-9339-2805